Literature DB >> 36259043

Clinical Indicators for Asthma-COPD Overlap: A Systematic Review and Meta-Analysis.

Junjie Peng1, Min Wang1, Yanqiu Wu1, Yongchun Shen1, Lei Chen1.   

Abstract

Background: Some clinical indicators have been reported to be useful in differentiating asthma-chronic obstructive pulmonary disease (COPD) overlap (ACO) from pure asthma/COPD, but the results were inconsistent. This study aims to evaluate the diagnostic value of these indicators for ACO.
Methods: Databases of PubMed, EMBASE, Ovid and Web of Science were retrieved. Pooled standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated in random-effects models.
Results: 48 eligible studies were included. The pooled results indicated, compared with pure asthma, ACO patients had lower levels of forced expiratory volume in the first second (FEV1)% predicted (pred) (SMD=-1.09, 95% CI -1.3 to -0.87), diffusion lung capacity for carbon monoxide (DLCO)% pred (SMD=-0.83, 95% CI -1.24 to -0.42), fractional exhaled nitric oxide (FeNO) (SMD=-0.23, 95% CI -0.36 to -0.11), and higher levels of induced sputum neutrophil (SMD = 0.51, 95% CI 0.21 to 0.81), circulating YKL-40 (SMD = 0.96, 95% CI 0.27 to 1.64). However, relative to COPD alone, ACO patients had higher levels of FEV1% pred (SMD = 0.15, 95% CI 0.05 to 0.26), DLCO% pred (SMD = 0.38, 95% CI 0.16 to 0.6), FeNO (SMD = 0.59, 95% CI 0.40 to 0.78), serum total immunoglobulin (Ig)E (SMD = 0.42, 95% CI 0.1 to 0.75), blood eosinophil (SMD = 0.44, 95% CI 0.29 to 0.59), induced sputum eosinophil (SMD = 0.62, 95% CI 0.42 to 0.83), and lower levels of induced sputum neutrophil (SMD=-0.48, 95% CI -0.7 to -0.27), circulating YKL-40 (SMD=-1.09, 95% CI -1.92 to -0.26).
Conclusion: Compared with pure asthma/COPD, ACO patients have different levels of FEV1% pred, DLCO% pred, FeNO, serum total IgE, blood eosinophil, induced sputum eosinophil/neutrophil, and circulating YKL-40, which could be helpful to establish a clinical diagnosis of ACO.
© 2022 Peng et al.

Entities:  

Keywords:  COPD; asthma; asthma-COPD overlap; indicators; meta-analysis

Mesh:

Substances:

Year:  2022        PMID: 36259043      PMCID: PMC9572492          DOI: 10.2147/COPD.S374079

Source DB:  PubMed          Journal:  Int J Chron Obstruct Pulmon Dis        ISSN: 1176-9106


  65 in total

1.  Comparison of Fractional Exhaled Nitric Oxide in Elderly Patients with Asthma-chronic Obstructive Pulmonary Disease Overlap and Other Airway Inflammatory Diseases.

Authors:  Fei Shi; Chen Qiu; Jie Yu; Ying Yang; Binbin Li; Mengjie Feng; Ting Zhang; Wenwen Liu
Journal:  Iran J Allergy Asthma Immunol       Date:  2018-06       Impact factor: 1.464

2.  Clinical characteristics of asthma combined with COPD feature.

Authors:  Hea Yon Lee; Ji Young Kang; Hyoung Kyu Yoon; Sook Young Lee; Soon Suk Kwon; Young Kyoon Kim; Chin Kook Rhee
Journal:  Yonsei Med J       Date:  2014-07       Impact factor: 2.759

Review 3.  Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.

Authors:  Donald P Tashkin; Michael E Wechsler
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-17

4.  Expression profiling of miRNA-145 and miRNA-338 in serum and sputum of patients with COPD, asthma, and asthma-COPD overlap syndrome phenotype.

Authors:  Donato Lacedonia; Grazia Pia Palladino; Maria Pia Foschino-Barbaro; Giulia Scioscia; Giovanna Elisiana Carpagnano
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-06-23

5.  Comparison of Clinical Characteristics and Short-Term Prognoses Within Hospitalized Chronic Obstructive Pulmonary Disease Patients Comorbid With Asthma, Bronchiectasis, and Their Overlaps: Findings From the ACURE Registry.

Authors:  Jieping Lei; Ting Yang; Chen Liang; Ke Huang; Sinan Wu; Chen Wang
Journal:  Front Med (Lausanne)       Date:  2022-02-25

6.  Fractional exhaled nitric oxide levels in asthma-COPD overlap syndrome: analysis of the National Health and Nutrition Examination Survey, 2007-2012.

Authors:  Tadahiro Goto; Carlos A Camargo; Kohei Hasegawa
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-07

7.  Smoking history and emphysema in asthma-COPD overlap.

Authors:  Kazuyoshi Kurashima; Yotaro Takaku; Chie Ohta; Noboru Takayanagi; Tsutomu Yanagisawa; Tetsu Kanauchi; Osamu Takahashi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-12-07

8.  Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach.

Authors:  Luis Pérez de Llano; Borja G Cosío; Amanda Iglesias; Natividad de Las Cuevas; Juan Jose Soler-Cataluña; Jose Luis Izquierdo; Jose Luis López-Campos; Carmen Calero; Vicente Plaza; Marc Miravitlles; Alfons Torrego; Eva Martinez-Moragon; Joan B Soriano; Antolin Lopez Viña; Irina Bobolea
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-02-12

9.  Increased urinary l-histidine in patients with asthma-COPD overlap: a pilot study.

Authors:  Jee Youn Oh; Young Seok Lee; Kyung Hoon Min; Gyu Young Hur; Sung Yong Lee; Kyung Ho Kang; Chin Kook Rhee; Seoung Ju Park; Adnan Khan; Jinhyuk Na; Youngja H Park; Jae Jeong Shim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-06-05

10.  Clinical, laboratory, and functional characteristics of asthma-COPD overlap in patients with a primary diagnosis of COPD.

Authors:  Ana Paula Adriano Queiroz; Fernanda Rodrigues Fonseca; Alexânia de Rê; Rosemeri Maurici
Journal:  J Bras Pneumol       Date:  2020-11-06       Impact factor: 2.624

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.